Lhermitte's sign following head and neck radiotherapy

Clinical Oncology

Volumn 12, Issue 2, 2000, Pages 98-103

  Lewanski, C R ^a   Sinclair, J A ^a   Stewart, J S W ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Lhermitte's sign; Myelopathy; Radiotherapy

Indexed keywords

ADULT; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; DOSE RESPONSE; FEMALE; HEAD AND NECK CANCER; HUMAN; MALE; PRIORITY JOURNAL; RADIATION DOSE; SPINAL CORD DISEASE;

EID: 0034062938     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1053/clon.2000.9125     Document Type: Article

References (16)

1. Boden WM. Radiation myelitis of the cervical spinal cord. Br J Radiol 1948;21:464-9.
2. Wang CC. Local control of oropharyngeal carcinoma after two accelerated hyperfractionation schemes. Int J Radiat Oncol Biol Phys 1988;14:1143-6.
3. Jones A. Transient radiation myeolopathy (with reference to Lhermitte's sign of electrical paraesthesia). Br J Radiol 1964;37:727-44.
4. Word JA, Kalokhe UP, Aron BS, et al. Transient radiation myelopathy (Lhermitte's sign) in patients with Hodgkin's disease treated by mantle irradiation. Int J Radiat Oncol Biol Phys 1980;6:1731-3.
5. Fein DA, Marcus RB, Parsons JT, et al. Lhermitte's sign: incidence and treatment variables influencing risk after irradiation of the cervical spinal cord. Int J Radiat Oncol Biol Phys 1993;27:1029-33.
6. Barendsen GW. Dose fractionation, dose-rate and isoeffect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys 1982;8:1991-7.
7. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989;62:679-94.
8. Thames HD, Hendry JH. Fractionation in radiotherapy. London, Taylor and Francis, 1987.
9. Dische S, Saunders M, Barrett A, et al. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 1997;44:123-6.
10. Joiner MC, Van der Kogel AJ. The linear-quadratic approach to fractionation and calculation of isoeffect relationships. In: Steel GG, editor. Basic clinical radiobiology. 2nd ed. London: Arnold,1997:106-21.
11. Koehler PJ, Verbiest H, Jager J, et al. Delayed radiation myelopathy: serial MR-imaging and pathology. Clin Neurol Neurosurg 1996;98:197-201.
12. Komachi H, Tsuchiya K, Ikeda M, et al. Radiation myelopathy: a clinicopathological study with special reference to correlation between MRI findings and neuropathology. J Neurol Sci 1995;132:228-32.
13. Alfonso ER, De Gregorio MA, Mateo P, et al. Radiation myelopathy in over-irradiated patients: MR imaging findings. Eur Radiol 1997;7:400-4.
14. Walther PJ, Rossitch E, Bullard DE. The development of Lhermitte's sign during cisplatin chemotherapy. Cancer 1987;60:2170-2.
15. Von Hoff DD, Reichert CM, Cuneo R, et al. Demyelinization of peripheral nerves associated with cis-diamminedichloroplatinum (II) DDP therapy [abstract]. Proc ASCO - AACR 1979;20:91.
16. Thornton AF, Zimberg SH, Greenberg HS, et al. Protracted Lhermitte's sign following head and neck irradiation. Arch Otolaryngol Head Neck Surg 1991;117:1300-3.